2017 American Transplant Congress
Outcomes of Recurrent Clostridium difficile Infection in Solid Organ Transplant Recipients.
Transplant Infectious Diseases, University Health Network, Toronto, ON, Canada
Introduction:Clostridium difficile infection(CDI) is one of the leading infectious causes among solid organ transplant (SOT) recipients. While the recurrence rate is relatively high, clinical outcomes…2016 American Transplant Congress
Continuous Antithymocyte Globulin (rATG) for Treatment of Renal Allograft Rejection: Preliminary Analysis of a Prospective, Randomized Trial.
Houston Methodist Hospital, Houston, TX.
Intravenous (IV) rATG for acute rejection (AR) is primarily given on an inpatient basis due to its daily administration, IV access requirement, and monitoring. The…2016 American Transplant Congress
Evaluation of Perioperative Anemia and Associated Transfusion Requirements in Adult Liver Transplant Recipients.
Aurora St Luke's Medical Center, Milwaukee, WI.
Background: Liver transplantation (LT) maybe associated with massive blood loss due to the complex hemostatic abnormalities of end-stage liver disease (ESLD) and surgical complexity. Blood…2016 American Transplant Congress
The Use of Perioperative Lactate Values as Markers for Adverse Outcomes in Liver Transplantation.
Introduction:We examined the utility of perioperative lactate values for the prediction of multiple post-transplant outcomes including length of hospital stay (LOS), acute cellular rejection (ACR),…2016 American Transplant Congress
Descriptive Epidemiology and Trends of Community Parenteral Antimicrobial Therapy Utilization Among Solid Organ Transplant Recipients at a High Volume Transplant Center 2008 to 2014.
Infectious Diseases, Cleveland Clinic, Cleveland, OH.
INTRODUCTION: Solid organ transplant (SOT) recipients may benefit from community-based parenteral anti-infective therapy (CoPAT). Limited data are available. CoPAT may help reduce LOS. As a…2016 American Transplant Congress
Enhanced Recovery After Kidney Transplantation: 48 Hour Length of Stay in Living and Deceased Donor Transplant Recipients.
BACKGROUND: Enhanced recovery after kidney transplantation is a desired outcome with potential value-enhancing benefits of reduced length of stay (LOS), costs, and risk of nosocomial…2016 American Transplant Congress
“Day 2 Discharge” After Kidney Transplantation: Complications, Health Care Utilization, and Long-Term Clinical Outcomes.
Transplant Center, Mayo Clinic, Phoenix.
Background: Reducing kidney transplant length of stay is a priority for many stakeholders. We aimed to determine whether very early discharge – on or before…2016 American Transplant Congress
Experience Using a Discharge Calculator for Discharge Planning Post Liver Transplantation (OLT).
Cleveland Clinic, Cleveland, OH.
We previously developed and validated a nomogram to predict discharge disposition post OLT. The current study analyzes our experience using the discharge calculator.Patients &Methods:We retrospectively…2015 American Transplant Congress
Generation, Cryopreservation, Function and In Vivo Fate of Ex-Vivo Expanded Cynomolgus
Background:Foxp3+ regulatory T cells (Treg) function to promote immune tolerance and prevent immunopathogenesis. Preclinical studies have demonstrated that adoptive transfer of Treg prevents rejection of…2015 American Transplant Congress
Outpatient Management of Delayed Graft Function (DGF) Is Associated With Reduced Length of Stay and Acute Rejection
Delayed graft function (DGF) increases hospital length of stay (LOS) and risk for readmission, rejection, early graft loss and death. We created a multidisciplinary DGF…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- Next Page »